搜索到 1000 条关于 송송넷 PB222.top 로라마녀실제 데이트VR유출 입사녀티비추천 zos 的文章

七夕节:话一话古代十大奇葩避孕方式

2016.08.09 七夕节:话一话古代十大奇葩避孕方式

CRACKED 网站为大家来盘点了历史上奇葩十大避孕措施,看完之后你会觉得没有什么不可能,妇产君反正已经看到下颌脱臼了。Top 10 黄鼠狼睾丸欧洲正处于「黑暗时代」时期...吧。Top 9 鳄鱼便便创造出了金字塔、木乃伊的古埃及人,在避孕这件事上可以说是煞费苦心,想法也算得上简单粗暴。想要避免怀孕?只要用一些东西堵住不让精子进入

2012.09.19 2011年生物仿制药会议(Biosimilars Asia 2011)

时间: 2011-5-23 至 2011-5-26
地点:Grand Hyatt Shanghai
主办单位: IBC Asia (S) Pte Ltd

会议简介

According to Business Insights, an estimated $25bn worth of biologics will lose patent protection by 2016, creating a significant market opportunity for biosimilars. However, the reality is that biosimilar development is a risk-fraught activity that demands significant resources in R&D, manufacturing expertise, regulatory know-how, clinical-trial capabilities, and a high level of financial investment.

Biosimilar development is riddled with complexities, ranging from regulatory, to manufacturing to marketing, and is one of the most expensive propositions in the pharmaceutical industry. It is estimated that it costs between US$100-200 million to bring a biosimilar product to market. With so much at stake, biosimilars represent not only substantial growth but equally risk..

IBC’s 2nd Annual Biosimilars Asia 2011 Summit is the ONLY conference in Asia catering to this region’s specific queries. With unprecedented insights from leading innovators and biosimilar companies, you will network and learn how to strategically position your company to maximize your ROI. Biosimilars Asia 2011 is attended by key stakeholders in the region and beyond, enabling you to make informed strategic decisions.

5 Reasons To Attend
  • Only conference in Asia which addresses concerns faced by the Asian biosimilar companies with experts from the region and beyond
  • Learn from and personally meet senior executives from the major stakeholders amongst from biosimilar to innovator companies
  • The most comprehensive event highlighting key challenges in the industry including manufacturing, marketing, pricing, transitioning from generics to biosimilars and regulatory issues
  • Showcasing unique case studies from leading Asian and international biosimilar companies
  • Gather the latest insights from regional biosimilar companies and MNCs about their strategic decisions and how they are positioning themselves for success

Industry Gurus / Speakers
Biocon, Pfizer, Genentech, Roche, Teva, Hospira, Sandoz, Momenta, Intas, Dr Reddy’s, Shenzhen Main Luck Pharmaceuticals

Past Attendees Include
Vice President, ASTRAZENECA INNOVATION CENTER (China)
Senior Director, GENENTECH INC, (USA)
Managing Director, BECTON DICKINSON CO (BD BIOSCIENCES) (Singapore)
Managing Director, ASAHI GLASS CO LTD (Japan)
Deputy General Manager, SINOPHARM (China)
Head, Biotech Research, USV LTD (India)
General Manager, JCR PHARMACEUTICALS CO LTD (Japan)
Vice President, R&D/Business Development, MAIN LUCK PHARMACEUTICALS INC (China)
Senior Research Associate, HANWHA CHEMICAL (South Korea)
Vice President, BOEHRINGER INGELHEIM GMBH (Germany)
General Manager, GLAXOSMITHKLINE (CHINA) INVESTMENT CO LTD (China)
IP Director, HOSPIRA (AUSTRALIA)
President, MYCENAX BIOTECH INC (Taiwan)
Senior Director, MERCK & CO INC (USA)
Associate Director, DR REDDY''''''''S LABORATORIES LTD (India)
Chairman, SHENZHEN SCIPROGEN BIO-PHARMACEUTICAL CO LTD (SCIPROGEN) (China)COO, SHANGHAI CELGEN BIOPHARMACEUTICALS (China)
Chief Representative, TTY BIOPHARM CO LTD (Taiwan)COO, 3SBIO (China)
Project Director, JIANGSU CHIA TAI TIANQING PHARMACEUTICAL CO LTD (China)Associate Director, PFIZER INVESTMENT CO LTD (China)
General Manager, NIPPON KAYAKU CO LTD (Japan)
President, HENLIUS BIOPHARMACEUTICALS INC & SHANGHAI HENLIUS BIOTECH (USA)
Vice President, RANBAXY (USA)

Registration

FEES per delegate
Early Bird Rate
Register & Pay before 11 March 2011
Special Rate
Register & Pay before 15 April 2011
Normal Rate
Register & Pay after 15 April 2011
Group Rate
Group of 3 or more
?
US$ / CNY
US$ / CNY
US$ / CNY
US$ / CNY
4 day package
(Conf + Pre & Post Workshops)
2,495 /
16,600
2,695 /
17,950
2,895 /
19,500
2,175 /
14,650
3.5 day package (Conf + Workshop C & A or B )

2,295 /
15,500

2,495 /
16,600
2,695 /
17,950
2,025 /
13,500
3 day package (Conf + Workshop A & B or C)
1,995 /
13,500
2,195 /
14,600
2,395 /
15,950

1,795 /
12,000

2.5 day package (Conf + Workshop A or B)
1,795 /
12,000
1,995 /
13,500
2,195 /
14,600
1,695 /
10,950
2 day package
(Conf only)
1,495 /
9,950
1,695 /
11,300
1,895 /
12,600
1,495 /
9,950

Register Now

PAYMENT TERMS

Payment must be received 10 business days prior to the event. To take advantage of discounts with an expiry cut-off date, registration and payment must be received by the cut off date.

Payments by Singapore Dollars (S$)

  • Payments by S$ bank draft or cheque should be made in favour of “IBC Asia (S) Pte Ltd” payable in Singapore.
  • Payment by telegraphic transfer in S$ must be made to:
    IBC Asia (S) Pte Ltd
    A/C No.: 147-059513-001 (SGD)
    The Hongkong and Shanghai Banking Corporation Limited
    21 Collyer Quay, HSBC Building, Singapore 049320
    Bank Swift Code: HSBCSGSG
    Bank Code: 7232
  • Payment by Credit Card (AMEX, VISA or MASTERCARD). Please provide your Card Number, Name of Cardholder, Expiry Date and your Signature and send it by fax to +65 6508 2407.
Payments by RMB (CNY)
  • Payment by telegraphic transfer in CNY must be made to:
    A/C Name:
    A/C No.: 720-031103-001
    Beneficiary Bank:
    Bank Address: No. 1000 Lujiazui Rind Road,
    Pudong, Shanghai 200120, P.R. China
    Bank Swift Code: HSBCCNSH
CANCELLATIONS SUBSTITUTION
Should you be unable to attend, a substitute delegate is welcome at no extra charge. Cancellations must be received in writing at least 10 business days before the start of the event, to receive a refund less 10% processing fee per registration. The company regrets that no refund will be made available for cancellation notifications received less than 10 business days before the event.IMPORTANT NOTE:
Please quote the name of the delegate, event title and invoice number on the advice when remitting payment. Bank charges are to be deducted from participating organisations own accounts. Please fax your payment details (copy of remittance advice, cheque or draft to +65 6508 2407.

Attendance will only be permitted upon receipt of full payment. Participants wishing to register at the door are responsible to ensure all details are as published. IBC Asia will not be responsible for any event re-scheduled or cancelled.


DATA PROTECTION
The personal information entered during your registration/order, or provided by you, will be held on a database and may be shared with companies in the Informa Group in the UK and internationally. Sometimes your details may be obtained from or shared with external companies for marketing purposes. If you do not wish your details to be used for this purpose, please contact Winnie Seah (Database) on winnie.seah@ibcasia.com.sg Tel: +65 6508 2468 or Fax: +65 6508 2408.
联系方式电话:+65 650 82401

2012.09.19 2010 第五届国际基因组学大会(ICG-V)

, please click: http://www.genomeconference.org/pages/Abstract.aspxTop Poster

2012.09.19 2012 中国医疗器械高峰论坛

trials and regulatory affairs
A special showcase of top 10 Chinese innovative device companies and top 5 selected US/EU device companies interested in China
心电图挑战:46 岁男性心悸一例

2015.07.28 心电图挑战:46 岁男性心悸一例

心动过速,心率 188 次/min,随后变成窄 QRS 波心动过速,心率增至 222 次/min。根据心电图表现,你认为最可能的诊断是什么?A. 房室结折返性...起始呈宽 QRS 波心动过速,心率 188 次/min,R 波呈单相,随后变成窄 QRS 波心动过速,心率增快至 222 次/min。该心电图鉴别诊断包括

2012.03.28 在神经胶质瘤中SP1表达上调并促进MMP-2介导细胞侵袭迁移和临床预后结果不佳

that the vast majority of 222 paraffin-embedded archival glioma specimens tested displayed...,Sp1在神经胶质瘤中的临床意义及生物学角色仍缺乏了解。在本研究中,我们发现Sp1在神经胶质瘤细胞系及组织中表达显著升高。对222例石蜡包埋神经胶质瘤组织标本的

2020.06.17 【直播 | 现场】计算机辅助设计—分子模拟与蛋白互作研讨班(8.20-22)

。【报名回执】访问此链接填写报名回执(https://www.wjx.top/jq/80710449.aspx)【咨询请联系】QQ 号:2814500767邮箱
心脏大血管外科

2020.09.17 心脏大血管外科

DRAGER Evita2dura、PB840 呼吸机、进口飞利浦 GE 监护仪、血液透析仪、主动脉内囊反博,先进的设备为危重病患复苏抢救提供了最有利的条件。在强大的专家
康复医学科喜获「2019 年华中区吞咽障碍康复病例大赛」二等奖

2019.07.19 康复医学科喜获「2019 年华中区吞咽障碍康复病例大赛」二等奖

技术)、VVST 容积粘度测试、吞咽造影检查(VFSS)、导管球囊扩张技术、安全摄食训练以及针灸、低频电刺激、门德尔松吞咽法、体外膈肌起搏、PB-K5 和说话瓣膜
重症医学科

2019.07.01 重症医学科

洁净病房,现代化的中央空调,中心供氧、负压吸引系统,床单位全部配备多功能防褥疮气垫床,紫外线消毒器。 配有美国 PB840 呼吸机、德国德尔格及美国鸟牌呼吸机
半相合供者可作为 MDS 移植替代选择

2016.11.10 半相合供者可作为 MDS 移植替代选择

每天)作为骨髓(G-BM)和外周血(G-PB)动员剂。目标单核细胞数为 ≥6 × 108/kg 受者体重。HID 预处理方案为:阿糖胞苷(4 g/m2/天,–10
光学光谱传输法可评估类风湿关节炎的疾病活动度

2016.02.23 光学光谱传输法可评估类风湿关节炎的疾病活动度

AA, Meijer PB, van Beek MC, Rensen WH, Bijlsma JW. Assessment of disease
研究人员找到人感染H7N9病毒致病机理

2014.12.16 研究人员找到人感染H7N9病毒致病机理

玉海博士介绍,研究显示,H7N9病毒的PB2、NP、M基因决定了病毒对哺乳动物的致病力,这三个内部基因与病毒表面血凝素(HA)和神经氨酸酶(NA)共同决定了病毒

2022.04.14 2021「中国高被引学者」单发布:清华浙大北大居高校前三

,其中6所大学的高被引学者数量超过了100位。清华大学共有222位,位居第一;浙江大学共有184位,位居第二;第三名为北京大学172位;第四、五名分别为上海

2019.03.18 2019年滴水湖第4届高峰论坛暨糖尿病慢性并发症的防治学科群管理模式国家级继续教育学习班

交通大学附属第六人民医院东院大礼堂(上海市浦东新区南汇新城镇环湖西三路222号)四、注册 费:0元/人 住宿费自理五、报名日期:2019年3月15--4月11日六
NASS2016:颈椎开门手术中椎板切除患者再手术率较未切除者高

2016.10.31 NASS2016:颈椎开门手术中椎板切除患者再手术率较未切除者高

再手术率及相关因素进行了系统分析。作者回顾性分析了 2005 年 1 月至 2012 年 10 月 31 日 222 例接受椎板成型术的患者,系统研究了术后

2016.02.23 注册

。即刻报名>>联系我们● 北方区域:李女士 010-85679966-222● 南方区域:沈

2015.05.22 NEJM:AZD9291用于T790M耐药突变的NSCLC疗效显著

的、先前EGFR-TKI治疗后疾病进展的晚期肺癌患者。剂量递增组31例、5个剂量扩增组222例,用药方案是每日一次20~240mg的AZD9291。研究终点
DAVF时软脑膜静脉回流直接与出血水肿相关

2014.07.03 DAVF时软脑膜静脉回流直接与出血水肿相关

静脉回流相比,前者与出血水肿更直接相关,研究发表于最新一期的《Neurology》杂志中。研究者评估了222例DAVF患者PVR或者CVR的发生与出血
上一页 1 2 3 ... 37 38 39 ... 48 49 50 下一页 到第